My Watchlist Items

      No Watchlist
Evelo Biosciences, Inc. (EVLO)
   1.83   0.03000009(+1.6666718%)
TitleNamePayCurrency PayGenderYear BornTitle Since
Chief People Officer Ms. Julie Carretero N/A USD female N/A N/A
Vice President & Head of Communications Ms. Jessica Cotrone N/A USD female N/A N/A
Gen. Counsel & Sec. Mr. Daniel S. Char N/A USD male N/A N/A
Head of Investor Relations & Capital Markets Ms. Kendra Sweeney N/A USD female N/A N/A
Chief Technical Operations & Quality Officer Dr. Chun Zhang Ph.D. N/A USD N/A N/A
Vice President & Chief Accounting Officer Mr. Stephen J. Carriere N/A USD male N/A N/A
Chief Financial Officer, Senior Vice President & Treasurer Mr. Luca Scavo N/A USD male N/A N/A
Chief Medical Officer Dr. Duncan McHale M.D., MBBS, Ph.D. N/A USD N/A N/A
Chief Scientific Officer and Pres of R&D Dr. Mark Bodmer N/A USD N/A N/A
Pres, Chief Executive Officer & Director Dr. Balkrishan Gill Ph.D. N/A USD N/A N/A
SymbolDateRatingRating Score Rating Details
EVLO 20 May, 2022 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Buy)
Rating DCF: (Strong Sell)
Rating DE: (Strong Sell)
Rating PE: (Sell)
Rating PB: (Strong Sell)
EVLO 19 May, 2022 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Buy)
Rating DCF: (Strong Sell)
Rating DE: (Strong Sell)
Rating PE: (Sell)
Rating PB: (Strong Sell)
EVLO 18 May, 2022 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Buy)
Rating DCF: (Strong Sell)
Rating DE: (Strong Sell)
Rating PE: (Sell)
Rating PB: (Strong Sell)
EVLO 17 May, 2022 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Buy)
Rating DCF: (Strong Sell)
Rating DE: (Strong Sell)
Rating PE: (Sell)
Rating PB: (Strong Sell)
EVLO 16 May, 2022 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Buy)
Rating DCF: (Strong Sell)
Rating DE: (Strong Sell)
Rating PE: (Sell)
Rating PB: (Strong Sell)
EVLO 13 May, 2022 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Buy)
Rating DCF: (Strong Sell)
Rating DE: (Strong Sell)
Rating PE: (Sell)
Rating PB: (Strong Sell)
EVLO 12 May, 2022 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Buy)
Rating DCF: (Strong Sell)
Rating DE: (Strong Sell)
Rating PE: (Sell)
Rating PB: (Strong Sell)
EVLO 11 May, 2022 B- 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Buy)
Rating DCF: (Strong Sell)
Rating DE: (Strong Sell)
Rating PE: (Sell)
Rating PB: (Strong Sell)
EVLO 10 May, 2022 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 9 May, 2022 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 6 May, 2022 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 5 May, 2022 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 4 May, 2022 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 3 May, 2022 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 29 April, 2022 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 28 April, 2022 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 27 April, 2022 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 26 April, 2022 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 25 April, 2022 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 22 April, 2022 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 21 April, 2022 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 20 April, 2022 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 19 April, 2022 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 18 April, 2022 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 15 April, 2022 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 14 April, 2022 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 13 April, 2022 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 12 April, 2022 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 11 April, 2022 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 8 April, 2022 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 7 April, 2022 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 6 April, 2022 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 5 April, 2022 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 4 April, 2022 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 1 April, 2022 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 31 March, 2022 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 30 March, 2022 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 29 March, 2022 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 28 March, 2022 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 25 March, 2022 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 24 March, 2022 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 23 March, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 22 March, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 21 March, 2022 B+ 3 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Strong Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 18 March, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 17 March, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 16 March, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 15 March, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 14 March, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 11 March, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 10 March, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 9 March, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 8 March, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 7 March, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 4 March, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 3 March, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 2 March, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 1 March, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 28 February, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 25 February, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 24 February, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 23 February, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 22 February, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 18 February, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 17 February, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 16 February, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 15 February, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 14 February, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 11 February, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 10 February, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 9 February, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 8 February, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 7 February, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 5 February, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 4 February, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 3 February, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 2 February, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 1 February, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 31 January, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 28 January, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 27 January, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 26 January, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 25 January, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 24 January, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 21 January, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 20 January, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 19 January, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 18 January, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 14 January, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 13 January, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 12 January, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 11 January, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 10 January, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 7 January, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 6 January, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 5 January, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 4 January, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 3 January, 2022 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 31 December, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
EVLO 30 December, 2021 B+ 4 Rating DCF: (Strong Buy)
Rating ROE: (Strong Sell)
Rating DCF: (Sell)
Rating DE: (Strong Buy)
Rating PE: (Sell)
Rating PB: (Strong Buy)
HolderSharesDate ReportedChange
MORGAN STANLEY 50294 31 March, 2022 -80
AMERITAS INVESTMENT PARTNERS, INC. 2381 31 March, 2022 0
DAIWA SECURITIES GROUP INC. 156 31 March, 2022 0
ALLIANCEBERNSTEIN L.P. 10400 31 March, 2022 -3500
AMERICAN INTERNATIONAL GROUP, INC. 15079 31 March, 2022 -1061
CUTLER GROUP LP 1100 31 March, 2022 -4971
VANGUARD GROUP INC 1544518 31 March, 2022 132702
FMR LLC 8046489 31 March, 2022 27497
GSA CAPITAL PARTNERS LLP 72871 31 March, 2022 72871
LLOYD ADVISORY SERVICES, LLC. 235 31 March, 2022 235
AE WEALTH MANAGEMENT LLC 31437 31 March, 2022 11909
BANK OF NEW YORK MELLON CORP 90946 31 March, 2022 -1757
HIGH NET WORTH ADVISORY GROUP LLC 500 31 March, 2022 0
SIMPLEX TRADING, LLC 60572 31 March, 2022 28472
STATE OF WISCONSIN INVESTMENT BOARD 25200 31 March, 2022 -10400
PROSHARE ADVISORS LLC 11224 31 March, 2022 -2938
CITIGROUP INC 2251 31 March, 2022 -7105
DEUTSCHE BANK AG\ 17582 31 March, 2022 -8418
NEW YORK STATE COMMON RETIREMENT FUND 15765 31 March, 2022 0
BELVEDERE TRADING LLC 172792 31 March, 2022 -68345
GROUP ONE TRADING, L.P. 452939 31 March, 2022 326630
BESSEMER GROUP INC 61289 31 March, 2022 0
RHUMBLINE ADVISERS 28825 31 March, 2022 4880
HARBOURVEST PARTNERS LLC 3063505 31 March, 2022 0
GEODE CAPITAL MANAGEMENT, LLC 545923 31 March, 2022 22348
BLACKROCK INC. 2064198 31 March, 2022 -43140
LARSON FINANCIAL GROUP LLC 739 31 March, 2022 -5140
TOWER RESEARCH CAPITAL LLC (TRC) 2858 31 March, 2022 -3821
JPMORGAN CHASE & CO 20505 31 March, 2022 4190
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM 10241 31 March, 2022 0
NORTHERN TRUST CORP 286971 31 March, 2022 -13465
NISA INVESTMENT ADVISORS, LLC 2600 31 March, 2022 2600
STATE OF MICHIGAN RETIREMENT SYSTEM 1100000 31 March, 2022 0
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 205003 31 March, 2022 3344
GROUP ONE TRADING, L.P. 126309 31 December, 2021 126309
DAIWA SECURITIES GROUP INC. 156 31 December, 2021 156
UBS GROUP AG 12588 31 December, 2021 11450
NUVEEN ASSET MANAGEMENT, LLC 94570 31 December, 2021 -6965
BANK OF AMERICA CORP /DE/ 34287 31 December, 2021 27331
ARTAL GROUP S.A. 1000000 31 December, 2021 0
VIRTUS ETF ADVISERS LLC 22257 31 December, 2021 9246
BNP PARIBAS ARBITRAGE, SA 6788 31 December, 2021 1096
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 16344 31 December, 2021 0
PARAMETRIC PORTFOLIO ASSOCIATES LLC 20075 31 December, 2021 0
VOYA INVESTMENT MANAGEMENT LLC 12008 31 December, 2021 -117
CRESSET ASSET MANAGEMENT, LLC 10000 31 December, 2021 0
WELLS FARGO & COMPANY/MN 12589 31 December, 2021 12589
CREDIT SUISSE AG/ 3566424 31 December, 2021 255513
QUANTBOT TECHNOLOGIES LP 3600 31 December, 2021 3600
BARCLAYS PLC 36864 31 December, 2021 24452
ROYAL BANK OF CANADA 6679 31 December, 2021 3383
CITADEL ADVISORS LLC 57773 31 December, 2021 57773
FLAGSHIP PIONEERING INC. 23030069 31 December, 2021 0
ALBERTA INVESTMENT MANAGEMENT CORP 40000 31 December, 2021 40000
STATE STREET CORP 560392 31 December, 2021 22049
GOLDMAN SACHS GROUP INC 49857 31 December, 2021 11365
HARBOURVEST PARTNERS LLC 3063505 31 December, 2021 0
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 24602 31 December, 2021 24602
NORGES BANK 294242 31 December, 2021 0
INVESCO LTD. 11377 31 December, 2021 500
TWO SIGMA ADVISERS, LLC 110500 31 December, 2021 -30100
LEGAL & GENERAL GROUP PLC 3264 31 December, 2021 51
MANUFACTURERS LIFE INSURANCE COMPANY, THE 16488 31 December, 2021 6005
TWO SIGMA INVESTMENTS LLC 13330 31 December, 2021 -3370
MILLENNIUM MANAGEMENT LLC 108457 31 December, 2021 89451
BELVEDERE TRADING LLC 241137 31 December, 2021 103386
ALPINE GLOBAL MANAGEMENT, LLC 14194 31 December, 2021 14194
HolderSharesDate ReportedWeight Percent
NEW YORK STATE COMMON RETIREMENT FUND 15765 31 March, 2022 N/A
Schwab U.S. Small-Cap ETF 43526 31 August, 2020 N/A
Vanguard Total Stock Market Index Fund 697917 31 August, 2020 N/A
iShares Russell 2000 ETF 363277 31 August, 2020 N/A
iShares Russell 2000 Growth ETF 128876 31 August, 2020 0.01
iShares Core S&P Total U.S. Stock Market ETF 56397 31 August, 2020 N/A
iShares Micro-Cap ETF 36443 31 August, 2020 0.02
Fidelity Growth Company K6 Fund 174311 31 July, 2020 0.01
Vanguard Russell 2000 Growth Index Fund 14529 31 July, 2020 0.01
Vanguard Balanced Index Fund 20029 31 July, 2020 N/A
Fidelity NASDAQ Composite Index Fund 19513 31 July, 2020 N/A
Vanguard Institutional Total Stock Market Index Fund 19293 31 July, 2020 N/A
Vanguard Russell 2000 Index Fund 18223 31 July, 2020 N/A
Fidelity Series Growth Company Fund 418340 31 July, 2020 0.01
Fidelity Select Biotechnology Portfolio 229599 31 July, 2020 0.01
Vanguard Extended Market Index Fund 72515 31 July, 2020 N/A
Fidelity Growth Company Fund 1973580 31 July, 2020 0.01
CREF Stock Account 10977 31 July, 2020 N/A
Fidelity Extended Market Index Fund 35269 31 July, 2020 N/A
Schwab Small-Cap Index Fund 29924 31 July, 2020 N/A
EQ/2000 Managed Volatility Portfolio 22411 31 July, 2020 N/A
VALIC Co I Small Cap Fund 13500 30 June, 2020 0.03
Bridgeway Ultra-Small Company Market Fund 55000 30 June, 2020 0.18
TIAA-CREF Small Cap Blend Index Fund 18024 30 June, 2020 N/A
iShares Russell 2000 Small-Cap Index Fund 22700 30 June, 2020 N/A
Fidelity Small Cap Index Fund 76899 30 April, 2020 N/A
Credit Suisse (Lux) Digital Health Equity Fund 1100000 31 January, 2019 N/A
SymbolTransaction DateReporting CikSecurities Owned Company CikReporting NameAcquistion Or DispositionForm Type Securities TransactedSecurity NameLink
EVLO 2 May, 2022 0001445826 5747 0001694665 Epstein David R D 4 2873 Restricted Stock Units View
EVLO 2 May, 2022 0001445826 4105 0001694665 Epstein David R D 4 2053 Restricted Stock Units View
EVLO 2 May, 2022 0001445826 66957 0001694665 Epstein David R A 4 2873 Common Stock View
EVLO 2 May, 2022 0001445826 64084 0001694665 Epstein David R A 4 2053 Common Stock View
EVLO 1 April, 2022 0001667657 40000 0001694665 Gutierrez-Ramos Jose-Carlos A 4 40000 Stock Option (Right to Buy) View
EVLO 1 April, 2022 0001917603 40000 0001694665 Williams Tonya A 4 40000 Stock Option (Right to Buy) View
EVLO 31 March, 2022 0001445826 8620 0001694665 Epstein David R D 4 2874 Restricted Stock Units View
EVLO 31 March, 2022 0001445826 6158 0001694665 Epstein David R D 4 2052 Restricted Stock Units View
EVLO 31 March, 2022 0001445826 62031 0001694665 Epstein David R A 4 2874 Common Stock View
EVLO 31 March, 2022 0001445826 59157 0001694665 Epstein David R A 4 2052 Common Stock View
EVLO 28 February, 2022 0001445826 11494 0001694665 Epstein David R D 4 2873 Restricted Stock Units View
EVLO 28 February, 2022 0001445826 8210 0001694665 Epstein David R D 4 2053 Restricted Stock Units View
EVLO 28 February, 2022 0001445826 57105 0001694665 Epstein David R A 4 2873 Common Stock View
EVLO 28 February, 2022 0001445826 54232 0001694665 Epstein David R A 4 2053 Common Stock View
EVLO 31 January, 2022 0001865558 1250 0001694665 Plinio Mark D. A 4 1250 Common Stock View
EVLO 31 January, 2022 0001445826 14367 0001694665 Epstein David R D 4 2873 Restricted Stock Units View
EVLO 31 January, 2022 0001445826 10263 0001694665 Epstein David R D 4 2052 Restricted Stock Units View
EVLO 31 January, 2022 0001445826 52179 0001694665 Epstein David R A 4 2873 Common Stock View
EVLO 31 January, 2022 0001445826 49306 0001694665 Epstein David R A 4 2052 Common Stock View
EVLO 19 January, 2022 0001239844 1417 0001694665 CARRIERE STEPHEN J A 4 1417 Restricted Stock Units View
EVLO 19 January, 2022 0001239844 6250 0001694665 CARRIERE STEPHEN J A 4 6250 Stock Option (Right to Buy) View
EVLO 19 January, 2022 0001757122 80000 0001694665 Char Daniel A 4 80000 Stock Option (Right to Buy) View
EVLO 19 January, 2022 0001837972 115000 0001694665 Zung Jonathan B. A 4 115000 Stock Option (Right to Buy) View
EVLO 19 January, 2022 0001865558 60000 0001694665 Plinio Mark D. A 4 60000 Stock Option (Right to Buy) View
EVLO 19 January, 2022 0001738885 125000 0001694665 Bodmer Mark A 4 125000 Stock Option (Right to Buy) View
EVLO 19 January, 2022 0001738896 100000 0001694665 McHale Duncan A 4 100000 Stock Option (Right to Buy) View
EVLO 19 January, 2022 0001864801 60000 0001694665 Scavo Luca A 4 60000 Stock Option (Right to Buy) View
EVLO 19 January, 2022 0001180763 300000 0001694665 GILL SIMBA A 4 300000 Stock Option (Right to Buy) View
EVLO 31 December, 2021 0001445826 17240 0001694665 Epstein David R D 4 2874 Restricted Stock Units View
EVLO 31 December, 2021 0001445826 12315 0001694665 Epstein David R D 4 2052 Restricted Stock Units View
EVLO 31 December, 2021 0001445826 47254 0001694665 Epstein David R A 4 2874 Common Stock View
EVLO 31 December, 2021 0001445826 44380 0001694665 Epstein David R A 4 2052 Common Stock View
EVLO 30 November, 2021 0001445826 20114 0001694665 Epstein David R D 4 2873 Restricted Stock Units View
EVLO 30 November, 2021 0001445826 14367 0001694665 Epstein David R D 4 2053 Restricted Stock Units View
EVLO 30 November, 2021 0001445826 42328 0001694665 Epstein David R A 4 2873 Common Stock View
EVLO 30 November, 2021 0001445826 39455 0001694665 Epstein David R A 4 2053 Common Stock View
EVLO 1 November, 2021 0001445826 22987 0001694665 Epstein David R D 4 2873 Restricted Stock Units View
EVLO 1 November, 2021 0001445826 16420 0001694665 Epstein David R D 4 2052 Restricted Stock Units View
EVLO 1 November, 2021 0001445826 37402 0001694665 Epstein David R A 4 2873 Common Stock View
EVLO 1 November, 2021 0001445826 34529 0001694665 Epstein David R A 4 2052 Common Stock View
EVLO 1 October, 2021 0001445826 25860 0001694665 Epstein David R D 4 2874 Restricted Stock Units View
EVLO 1 October, 2021 0001445826 18472 0001694665 Epstein David R D 4 2053 Restricted Stock Units View
EVLO 1 October, 2021 0001445826 32477 0001694665 Epstein David R A 4 2874 Common Stock View
EVLO 1 October, 2021 0001445826 29603 0001694665 Epstein David R A 4 2053 Common Stock View
EVLO 3 September, 2021 0001445826 21804 0001694665 Epstein David R A 4 4104 Common Stock View
EVLO 3 September, 2021 0001445826 27550 0001694665 Epstein David R A 4 5746 Common Stock View
EVLO 3 September, 2021 0001445826 20525 0001694665 Epstein David R D 4 4104 Restricted Stock Units View
EVLO 3 September, 2021 0001445826 28734 0001694665 Epstein David R D 4 5746 Restricted Stock Units View
EVLO 2 September, 2021 0001881757 35000 0001694665 McInnes Iain B. A 4 35000 Stock Option (Right to Buy) View
EVLO 30 June, 2021 0001445826 24629 0001694665 Epstein David R A 4 24629 Restricted Stock Units View
EVLO 30 June, 2021 0001445826 34480 0001694665 Epstein David R A 4 34480 Restricted Stock Units View
EVLO 14 June, 2021 0001865558 250000 0001694665 Plinio Mark D. A 4 250000 Stock Option (Right to Buy) View
EVLO 9 June, 2021 0001760670 1810 0001694665 Andres Juan A 4 1810 Stock Option (Right to Buy) View
EVLO 9 June, 2021 0001105941 1810 0001694665 PERRY DAVID P A 4 1810 Stock Option (Right to Buy) View
EVLO 9 June, 2021 0001216078 1810 0001694665 MELAS KYRIAZI THEO A 4 1810 Stock Option (Right to Buy) View
EVLO 9 June, 2021 0001738865 1810 0001694665 Darzi Lord Ara A 4 1810 Stock Option (Right to Buy) View
EVLO 8 June, 2021 0001760670 15690 0001694665 Andres Juan A 4 15690 Stock Option (Right to Buy) View
EVLO 8 June, 2021 0001105941 15690 0001694665 PERRY DAVID P A 4 15690 Stock Option (Right to Buy) View
EVLO 8 June, 2021 0001216078 15690 0001694665 MELAS KYRIAZI THEO A 4 15690 Stock Option (Right to Buy) View
EVLO 8 June, 2021 0001738865 15690 0001694665 Darzi Lord Ara A 4 15690 Stock Option (Right to Buy) View
EVLO 1 June, 2021 0001864801 300000 0001694665 Scavo Luca A 4 300000 Stock Option (Right to Buy) View
EVLO 1 June, 2021 0001864801 4545 0001694665 Scavo Luca A 4 4545 Restricted Stock Units View
EVLO 9 April, 2021 0001487179 31380 0001694665 McHugh Julie A 4 31380 Stock Option (Right to Buy) View
EVLO 2 February, 2021 0001508051 3207312 0001694665 Flagship Ventures Fund IV General Partner LLC A 4 37143 Common Stock View
EVLO 2 February, 2021 0001508051 791529 0001694665 Flagship Ventures Fund IV General Partner LLC A 4 9285 Common Stock View
EVLO 2 February, 2021 0001508051 1370476 0001694665 Flagship Ventures Fund IV General Partner LLC A 4 37143 Common Stock View
EVLO 2 February, 2021 0001508051 4125461 0001694665 Flagship Ventures Fund IV General Partner LLC A 4 46429 Common Stock View
EVLO 27 January, 2021 0001738885 179000 0001694665 Bodmer Mark A 4 179000 Stock Option (Right to Buy) View
EVLO 27 January, 2021 0001695378 31380 0001694665 Hohneker John A 4 31380 Stock Option (Right to Buy) View
EVLO 27 January, 2021 0001805198 24000 0001694665 Liu Xiaoli Jacqueline A 4 24000 Stock Option (Right to Buy) View
EVLO 27 January, 2021 0001805198 5680 0001694665 Liu Xiaoli Jacqueline A 4 5680 Restricted Stock Units View
EVLO 27 January, 2021 0001757122 57000 0001694665 Char Daniel A 4 57000 Stock Option (Right to Buy) View
EVLO 27 January, 2021 0001738896 96500 0001694665 McHale Duncan A 4 96500 Stock Option (Right to Buy) View
EVLO 27 January, 2021 0001180763 275000 0001694665 GILL SIMBA A 4 275000 Stock Option (Right to Buy) View
EVLO 27 January, 2021 0001837972 300000 0001694665 Zung Jonathan B. A 4 300000 Stock Option (Right to Buy) View
EVLO 27 January, 2021 0001837972 10000 0001694665 Zung Jonathan B. A 4/A 10000 Restricted Stock Units View
EVLO 11 December, 2020 0001445826 15200 0001694665 Epstein David R A 4 4970 Common Stock View
EVLO 11 December, 2020 0001445826 16000 0001694665 Epstein David R A 4 800 Common Stock View
EVLO 11 December, 2020 0001445826 17000 0001694665 Epstein David R A 4 1000 Common Stock View
EVLO 11 December, 2020 0001445826 17500 0001694665 Epstein David R A 4 500 Common Stock View
EVLO 11 December, 2020 0001445826 17700 0001694665 Epstein David R A 4 200 Common Stock View
EVLO 11 December, 2020 0001445826 10200 0001694665 Epstein David R A 4 200 Common Stock View
EVLO 11 December, 2020 0001445826 10230 0001694665 Epstein David R A 4 30 Common Stock View
EVLO 1 December, 2020 0001805198 0 0001694665 Liu Xiaoli Jacqueline D 4 3000 Common Stock View
EVLO 11 October, 2020 0001445826 59395 0001694665 Epstein David R A 4 59395 Stock Option (Right to Buy) View
EVLO 11 October, 2020 0001445826 44743 0001694665 Epstein David R A 4 44743 Stock Option (Right to Buy) View
EVLO 31 August, 2020 0001445826 10000 0001694665 Epstein David R A 4 1000 Common Stock View
EVLO 31 August, 2020 0001445826 7000 0001694665 Epstein David R A 4 2752 Common Stock View
EVLO 31 August, 2020 0001445826 8000 0001694665 Epstein David R A 4 1000 Common Stock View
EVLO 31 August, 2020 0001445826 9000 0001694665 Epstein David R A 4 1000 Common Stock View
EVLO 28 August, 2020 0001445826 1000 0001694665 Epstein David R A 4 1000 Common Stock View
EVLO 28 August, 2020 0001445826 4248 0001694665 Epstein David R A 4 3248 Common Stock View
EVLO 10 July, 2020 0001805198 30000 0001694665 Liu Xiaoli Jacqueline A 4 30000 Stock Option (Right to Buy) View
EVLO 29 June, 2020 0001508051 3170169 0001694665 Flagship Ventures Fund IV General Partner LLC A 4 1333333 Common Stock View
EVLO 29 June, 2020 0001508051 782244 0001694665 Flagship Ventures Fund IV General Partner LLC A 4 333333 Common Stock View
EVLO 29 June, 2020 0001508051 1333333 0001694665 Flagship Ventures Fund IV General Partner LLC A 4 1333333 Common Stock View
EVLO 29 June, 2020 0001508051 4079032 0001694665 Flagship Ventures Fund IV General Partner LLC A 4 1666667 Common Stock View
EVLO 17 June, 2020 0001216078 15690 0001694665 MELAS KYRIAZI THEO A 4 15690 Stock Option (Right to Buy) View
EVLO 17 June, 2020 0001359574 15690 0001694665 Simonian Nancy A A 4 15690 Stock Option (Right to Buy) View
EVLO 17 June, 2020 0001738865 15690 0001694665 Darzi Lord Ara A 4 15690 Stock Option (Right to Buy) View
SymbolDatePeriodDownload XLSX File
EVLO 2021 FY Download XLSX File
EVLO 2020 FY Download XLSX File
EVLO 2019 FY Download XLSX File
EVLO 2018 FY Download XLSX File
EVLO 2021 Q3 Download XLSX File
EVLO 2021 Q1 Download XLSX File
EVLO 2021 Q2 Download XLSX File
EVLO 2021 Q4 Download XLSX File
EVLO 2020 Q3 Download XLSX File
EVLO 2020 Q4 Download XLSX File
EVLO 2020 Q1 Download XLSX File
EVLO 2020 Q2 Download XLSX File
EVLO 2019 Q3 Download XLSX File
EVLO 2019 Q4 Download XLSX File
EVLO 2019 Q1 Download XLSX File
EVLO 2019 Q2 Download XLSX File
EVLO 2018 Q2 Download XLSX File
EVLO 2018 Q4 Download XLSX File
EVLO 2018 Q1 Download XLSX File
EVLO 2018 Q3 Download XLSX File

Charts

Company Historical Earnings

DateSymbolEPSEPS EstimatedTimeRevenueRevenue Estimated
12 May, 2022 EVLO -0.56 -0.56 bmo 0
24 March, 2022 EVLO -0.54 -0.54 bmo 0 0
28 October, 2021 EVLO -0.63 -0.63 bmo 0 0
29 July, 2021 EVLO -0.59 -0.59 bmo 0 0
29 April, 2021 EVLO -0.55 -0.55 bmo 0 0
9 March, 2021 EVLO -0.62 -0.62 bmo 0 0
29 October, 2020 EVLO -0.45 -0.45 bmo 0 0
30 July, 2020 EVLO -0.63 -0.63 bmo 0 0
11 May, 2020 EVLO -0.71 -0.71 bmo 0 0
13 February, 2020 EVLO -0.7 -0.7 bmo 0 0
5 November, 2019 EVLO -0.67 -0.67 bmo 0 0
6 August, 2019 EVLO -0.65 -0.65 bmo 0 0
2 May, 2019 EVLO -0.64 -0.64 bmo 0 0
14 February, 2019 EVLO -0.49 -0.49 bmo 0 0
1 November, 2018 EVLO -0.5 -0.5 bmo 0 0
2 August, 2018 EVLO -0.85 -0.85 bmo 0 0
31 May, 2018 EVLO bmo 0 0

Company Profile

Company Name Evelo Biosciences, Inc.
Symbol EVLO
Currency USD
Price 1.83
Exchange Name NASDAQ Global Select (NASDAQ)
Industry Biotechnology
CEO Dr. Balkrishan Gill
Sector Healthcare
Country US
Full Time Employees 122
Phone 16178708281
Address 620 Memorial Dr Ste 200
City Cambridge
State MASSACHUSETTS
Zip 02139
Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hyperinflammatory response associated with COVID-19. The company also develops EDP1867, an inactivated investigational oral biologic, which is in Phase 1b for the treatment of inflammatory diseases; EDP2939, an extracellular vesicle investigational oral biologic for the treatment of inflammatory diseases; and EDP1908, a product candidate for oncology. Evelo Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
>

FREE

Get the most important news and analyses for Free.

Thank you for subscribing.

Something went wrong.